The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B).
about
Muscle fatigue, nNOS and muscle fiber atrophy in limb girdle muscular dystrophyLimb-girdle muscular dystrophy subtypes: First-reported cohort from northeastern China.Calpain 3 is important for muscle regeneration: evidence from patients with limb girdle muscular dystrophies.Identification of two novel SMCHD1 sequence variants in families with FSHD-like muscular dystrophy.Dysferlinopathy course and sportive activity: clues for possible treatmentPatients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity.Genetic profile for suspected dysferlinopathy identified by targeted next-generation sequencing.Screening two mutations in the dysferlin gene by exon capture and sequence analysis: A case report.Genetic silencing of Nrf2 enhances X-ROS in dysferlin-deficient muscle.Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: The yield and the pitfalls.Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.Progress and challenges in diagnosis of dysferlinopathy.Reply: Dominant LGMD2A: alternative diagnosis or hidden digenism?Dominant LGMD2A: alternative diagnosis or hidden digenism?
P2860
Q28083989-F42E6A3F-1257-41AF-A567-B5ECF9CA32C1Q34094843-73B5B88C-8C58-48E0-B67E-2F1EA7B47A2CQ34207404-0846F40E-4F31-4DF7-90DC-29B588E9B9D8Q34705103-5F46890C-980B-43A4-8916-1D02F5AD0D87Q35607518-8DCA6620-71AF-4106-B331-4F4DDDEACC13Q36576057-75D45A61-50C4-444D-A399-7AB60A43A6E9Q36738610-EBB3F66A-75F5-45B8-BCC2-18A8987CA522Q37001720-5B0981A9-7A1A-48F1-9F56-95A6AE0FD7D5Q37592086-DD4E5F17-4321-4629-8B55-3867F906D4C3Q38434135-04F62C08-92E2-4392-BCEA-08771E0A0C84Q38553524-98502BC2-7A2B-46F1-8D60-9559704D2E09Q38921880-2D3AA6EF-AA86-47A1-884B-F613C0E98879Q48332617-37DC3E97-B5BF-45BB-A268-B01627179E7EQ48438116-41AB827D-3F13-4FB5-B1F8-B5B40219672F
P2860
The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B).
@en
The clinical course of calpainopathy
@nl
type
label
The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B).
@en
The clinical course of calpainopathy
@nl
prefLabel
The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B).
@en
The clinical course of calpainopathy
@nl
P2093
P2860
P356
P1476
The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B).
@en
P2093
P2860
P356
10.1179/174313209X380847
P577
2010-02-01T00:00:00Z